De Burlo Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
De Burlo Group's LLY Position: Q1 2026 in Review
De Burlo Group reduced its Eli Lilly (LLY) stake by 38% in Q1 2026, selling an estimated $16.5M and leaving 26,518 shares worth $24.4M. The position accounts for 5.53% of the portfolio, ranked #3.
De Burlo Group first reported a position in LLY in Q3 2018 and has held it in 27 quarters since. The position peaked at $46M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- De Burlo Group held 26,518 shares of Eli Lilly worth $24.4M as of Q1 2026.
- De Burlo Group sold 16,260 Eli Lilly shares in Q1 2026, an estimated $16.5M.
- Eli Lilly made up 5.53% of De Burlo Group's portfolio in Q1 2026, its #3 holding.
- De Burlo Group first reported a position in Eli Lilly in Q3 2018 and has held it in 27 quarters since.
- De Burlo Group's Eli Lilly position peaked at $46M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on De Burlo Group's 13F filing for Q1 2026, filed 14 May 2026.